drugset / Trial / NCT02675335

Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin

NCT02675335

Phase 3 Withdrawn Wolfgang-Michael Franz
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to test the effect of Sitagliptin on the healing of stable, nonhealing diabetic foot ulcers. This is a randomized placebo-controlled Trial.

Timeline

Start
2016-03
Primary completion
2017-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sitagliptin Small molecule 100 mg

Indications

No indication recorded.